Stuart Poulton's Insider Trades & SAST Disclosures

Stuart Poulton's most recent trade in Karyopharm Therapeutics Inc was a trade of 888 Common Stock done . Disclosure was reported to the exchange on Sept. 12, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Karyopharm Therapeutics Inc
Stuart Poulton EVP, Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Sep 2025 888 28,111 (0%) 0% 0 Common Stock
Karyopharm Therapeutics Inc
Stuart Poulton EVP, Chief Development Officer Sale of securities on an exchange or to another person at price $ 6.43 per share. 12 Sep 2025 401 27,710 (0%) 0% 6.4 2,578 Common Stock
Karyopharm Therapeutics Inc
Stuart Poulton EVP, Chief Development Officer Sale of securities on an exchange or to another person at price $ 4.37 per share. 29 Jul 2025 191 27,223 (0%) 0% 4.4 835 Common Stock
Karyopharm Therapeutics Inc
Stuart Poulton EVP, Chief Development Officer Sale of securities on an exchange or to another person at price $ 6.29 per share. 04 Mar 2025 3,548 27,414 (0%) 0% 6.3 22,317 Common Stock
Karyopharm Therapeutics Inc
Stuart Poulton EVP, Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2025 10,000 10,000 - - Stock Option (right to buy)
Karyopharm Therapeutics Inc
Stuart Poulton EVP, Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2025 9,166 9,166 - - Stock Option (right to buy)
Karyopharm Therapeutics Inc
Stuart Poulton EVP, Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2025 5,000 26,379 (0%) 0% 0 Common Stock
Karyopharm Therapeutics Inc
Stuart Poulton EVP, Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2025 4,583 30,962 (0%) 0% 0 Common Stock
Karyopharm Therapeutics Inc
Stuart Poulton EVP, Chief Development Officer Sale of securities on an exchange or to another person at price $ 0.63 per share. 18 Feb 2025 5,914 320,714 (0%) 0% 0.6 3,726 Common Stock
Karyopharm Therapeutics Inc
Stuart Poulton EVP, Chief Development Officer Sale of securities on an exchange or to another person at price $ 1.06 per share. 30 Jul 2024 2,883 326,628 (0%) 0% 1.1 3,056 Common Stock
Karyopharm Therapeutics Inc
Stuart Poulton EVP, Chief Development Officer Sale of securities on an exchange or to another person at price $ 1.17 per share. 29 Feb 2024 16,311 335,666 (0%) 0% 1.2 19,084 Common
Karyopharm Therapeutics Inc
Stuart Poulton EVP, Chief Development Officer Sale of securities on an exchange or to another person at price $ 1.20 per share. 29 Feb 2024 6,155 329,511 (0%) 0% 1.2 7,386 Common
Karyopharm Therapeutics Inc
Stuart Poulton EVP, Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2024 188,205 351,977 (0%) 0% 0 Common Stock
Karyopharm Therapeutics Inc
Stuart Poulton EVP, Chief Development Officer Sale of securities on an exchange or to another person at price $ 1.33 per share. 15 Feb 2024 5,748 163,871 (0%) 0% 1.3 7,645 Common Stock
Karyopharm Therapeutics Inc
Poulton Stuart EVP, Chief Development Officer Sale of securities on an exchange or to another person at price $ 1.40 per share. 15 Feb 2024 99 163,772 (0%) 0% 1.4 139 Common Stock
Karyopharm Therapeutics Inc
Stuart Poulton EVP, Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2024 13,333 169,619 (0%) 0% 0 Common Stock
Karyopharm Therapeutics Inc
Stuart Poulton EVP, Chief Development Officer Sale of securities on an exchange or to another person at price $ 1.70 per share. 28 Jul 2023 2,845 156,286 (0%) 0% 1.7 4,837 Common Stock
Karyopharm Therapeutics Inc
Stuart Poulton EVP, Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2023 95,000 159,131 (0%) 0% 0 Common Stock
Karyopharm Therapeutics Inc
Stuart Poulton EVP, Chief Development Officer Sale of securities on an exchange or to another person at price $ 3.19 per share. 15 Feb 2023 5,665 64,335 (0%) 0% 3.2 18,071 Common Stock
Karyopharm Therapeutics Inc
Stuart Poulton EVP, Chief Development Officer Sale of securities on an exchange or to another person at price $ 3.16 per share. 15 Feb 2023 196 64,131 (0%) 0% 3.2 619 Common Stock
Karyopharm Therapeutics Inc
Stuart Poulton EVP, Chief Development Officer Sale of securities on an exchange or to another person at price $ 3.25 per share. 15 Feb 2023 8 64,327 (0%) 0% 3.3 26 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades